Hollsteen
← Lam Research

Total liabilities & equity

Balance – as of period end · $B

QuartersFiscal years

$BTotal liabilities & equity · Q1 FY2016: $9.6B · 10-Q 0001193125-15-364406 filed Nov 3, 2015Total liabilities & equity · Q2 FY2016: $9.8B · 10-Q 0001628280-16-010687 filed Feb 3, 2016Total liabilities & equity · Q3 FY2016: $10.0B · 10-Q 0000707549-16-000014 filed Apr 25, 2016Total liabilities & equity · Q4 FY2016: $12.3B · 10-K 0000707549-17-000100 filed Aug 15, 2017Total liabilities & equity · Q1 FY2017: $12.6B · 10-Q 0000707549-16-000085 filed Oct 25, 2016Total liabilities & equity · Q2 FY2017: $11.5B · 10-Q 0000707549-17-000010 filed Jan 30, 2017Total liabilities & equity · Q3 FY2017: $11.9B · 10-Q 0000707549-17-000056 filed Apr 24, 2017Total liabilities & equity · Q4 FY2017: $12.1B · 10-K 0000707549-17-000100 filed Aug 15, 2017Total liabilities & equity · Q1 FY2018: $12.4B · 10-Q 0000707549-17-000139 filed Oct 23, 2017Total liabilities & equity · Q2 FY2018: $12.9B · 10-Q 0000707549-18-000016 filed Jan 30, 2018Total liabilities & equity · Q3 FY2018: $13.7B · 10-Q 0000707549-18-000084 filed Apr 24, 2018Total liabilities & equity · Q4 FY2018: $12.5B · 10-K 0000707549-18-000115 filed Aug 14, 2018Total liabilities & equity · Q1 FY2019: $11.0B · 10-Q 0000707549-18-000125 filed Oct 23, 2018Total liabilities & equity · Q2 FY2019: $10.8B · 10-Q 0000707549-19-000008 filed Jan 30, 2019Total liabilities & equity · Q3 FY2019: $12.9B · 10-Q 0000707549-19-000078 filed Apr 30, 2019Total liabilities & equity · Q4 FY2019: $12.0B · 10-K 0000707549-19-000124 filed Aug 20, 2019Total liabilities & equity · Q1 FY2020: $12.3B · 10-Q 0000707549-19-000163 filed Oct 29, 2019Total liabilities & equity · Q2 FY2020: $11.9B · 10-Q 0000707549-20-000020 filed Feb 4, 2020Total liabilities & equity · Q3 FY2020: $12.9B · 10-Q 0000707549-20-000081 filed Apr 28, 2020Total liabilities & equity · Q4 FY2020: $14.6B · 10-K 0000707549-20-000138 filed Aug 18, 2020Total liabilities & equity · Q1 FY2021: $15.1B · 10-Q 0000707549-20-000173 filed Oct 27, 2020Total liabilities & equity · Q2 FY2021: $15.4B · 10-Q 0000707549-21-000017 filed Feb 2, 2021Total liabilities & equity · Q3 FY2021: $15.3B · 10-Q 0000707549-21-000089 filed Apr 28, 2021Total liabilities & equity · Q4 FY2021: $15.9B · 10-K 0000707549-21-000136 filed Aug 17, 2021Total liabilities & equity · Q1 FY2022: $15.6B · 10-Q 0000707549-21-000155 filed Oct 26, 2021Total liabilities & equity · Q2 FY2022: $16.7B · 10-Q 0000707549-22-000012 filed Feb 1, 2022Total liabilities & equity · Q3 FY2022: $16.6B · 10-Q 0000707549-22-000067 filed Apr 26, 2022Total liabilities & equity · Q4 FY2022: $17.2B · 10-K 0000707549-22-000107 filed Aug 24, 2022Total liabilities & equity · Q1 FY2023: $18.7B · 10-Q 0000707549-22-000124 filed Oct 24, 2022Total liabilities & equity · Q2 FY2023: $19.2B · 10-Q 0000707549-23-000008 filed Jan 30, 2023Total liabilities & equity · Q3 FY2023: $19.2B · 10-Q 0000707549-23-000081 filed Apr 24, 2023Total liabilities & equity · Q4 FY2023: $18.8B · 10-K 0000707549-23-000102 filed Aug 15, 2023Total liabilities & equity · Q1 FY2024: $18.5B · 10-Q 0000707549-23-000115 filed Oct 23, 2023Total liabilities & equity · Q2 FY2024: $18.8B · 10-Q 0000707549-24-000016 filed Jan 29, 2024Total liabilities & equity · Q3 FY2024: $18.3B · 10-Q 0000707549-24-000067 filed Apr 29, 2024Total liabilities & equity · Q4 FY2024: $18.7B · 10-K 0000707549-24-000106 filed Aug 29, 2024Total liabilities & equity · Q1 FY2025: $19.5B · 10-Q 0000707549-24-000128 filed Oct 28, 2024Total liabilities & equity · Q2 FY2025: $19.8B · 10-Q 0000707549-25-000014 filed Jan 31, 2025Total liabilities & equity · Q3 FY2025: $20.0B · 10-Q 0000707549-25-000054 filed Apr 25, 2025Total liabilities & equity · Q4 FY2025: $21.3B · 10-K 0000707549-25-000075 filed Aug 11, 2025Total liabilities & equity · Q1 FY2026: $21.9B · 10-Q 0000707549-25-000085 filed Oct 24, 2025Total liabilities & equity · Q2 FY2026: $21.4B · 10-Q 0000707549-26-000009 filed Jan 29, 2026Total liabilities & equity · Q3 FY2026: $20.8B · 10-Q 0000707549-26-000022 filed Apr 23, 2026Total liabilities & equity · Q4 FY2026: $23.5B · 10-K 0000707549-26-000037 filed Aug 7, 202612.123.59.6Q1 FY2016Q4 FY2026Q4 FY2017
$BTotal liabilities & equity · Q4 FY2016: $12.3B · 10-K 0000707549-17-000100 filed Aug 15, 2017Total liabilities & equity · Q1 FY2017: $12.6B · 10-Q 0000707549-16-000085 filed Oct 25, 2016Total liabilities & equity · Q2 FY2017: $11.5B · 10-Q 0000707549-17-000010 filed Jan 30, 2017Total liabilities & equity · Q3 FY2017: $11.9B · 10-Q 0000707549-17-000056 filed Apr 24, 2017Total liabilities & equity · Q4 FY2017: $12.1B · 10-K 0000707549-17-000100 filed Aug 15, 2017Total liabilities & equity · Q1 FY2018: $12.4B · 10-Q 0000707549-17-000139 filed Oct 23, 2017Total liabilities & equity · Q2 FY2018: $12.9B · 10-Q 0000707549-18-000016 filed Jan 30, 2018Total liabilities & equity · Q3 FY2018: $13.7B · 10-Q 0000707549-18-000084 filed Apr 24, 201812.113.712.3Q4 FY2016Q3 FY2018Q4 FY2017
Q4 FY2017
12.1$B
All values (44)
PeriodValue ($B)Status
Q4 FY202623.5reported
Q3 FY202620.8reported
Q2 FY202621.4reported
Q1 FY202621.9reported
Q4 FY202521.3reported
Q3 FY202520.0reported
Q2 FY202519.8reported
Q1 FY202519.5reported
Q4 FY202418.7reported
Q3 FY202418.3reported
Q2 FY202418.8reported
Q1 FY202418.5reported
Q4 FY202318.8reported
Q3 FY202319.2reported
Q2 FY202319.2reported
Q1 FY202318.7reported
Q4 FY202217.2reported
Q3 FY202216.6reported
Q2 FY202216.7reported
Q1 FY202215.6reported
Q4 FY202115.9reported
Q3 FY202115.3reported
Q2 FY202115.4reported
Q1 FY202115.1reported
Q4 FY202014.6reported
Q3 FY202012.9reported
Q2 FY202011.9reported
Q1 FY202012.3reported
Q4 FY201912.0reported
Q3 FY201912.9reported
Q2 FY201910.8reported
Q1 FY201911.0reported
Q4 FY201812.5reported
Q3 FY201813.7reported
Q2 FY201812.9reported
Q1 FY201812.4reported
Q4 FY201712.1reported
Q3 FY201711.9reported
Q2 FY201711.5reported
Q1 FY201712.6reported
Q4 FY201612.3reported
Q3 FY201610.0reported
Q2 FY20169.8reported
Q1 FY20169.6reported

CSV with all sources · Technical ID: liabilities_and_equity

More metrics for Lam Research

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Sources & calculation
Value
$12.1B
Period
Q4 FY2017, ended Jun 25, 2017 · as of Jun 25, 2017 (balance as of date, not a sum)
Source
10-K, filed Aug 15, 2017 · 0000707549-17-000100
Location
us-gaap:LiabilitiesAndStockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$12.1BAug 15, 201710-K 0000707549-17-000100reported · confidence 1. · current